{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:52:41Z","timestamp":1793857961186,"version":"4.6.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.revmed.2024.10.011","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T07:26:44Z","timestamp":1730446004000},"page":"12-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["French protocol for the diagnosis and management of giant cell arteritis"],"prefix":"10.1016","volume":"46","author":[{"given":"Hubert","family":"de Boysson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Devauchelle-Pensec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1156-0607","authenticated-orcid":false,"given":"Christian","family":"Agard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9008-701X","authenticated-orcid":false,"given":"Marc","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Bienvenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7229-3808","authenticated-orcid":false,"given":"Bernard","family":"Bonnotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5281-5445","authenticated-orcid":false,"given":"Guillermo","family":"Carvajal Alegria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0821-9990","authenticated-orcid":false,"given":"Olivier","family":"Espitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Heron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9398-2968","authenticated-orcid":false,"given":"Jean-Christophe","family":"Lega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Heang","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e8ne","family":"Mekinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7545-6385","authenticated-orcid":false,"given":"Jacques","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Regent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Richez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-6903","authenticated-orcid":false,"given":"Laurent","family":"Sailler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00e8le","family":"Seror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tournadre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6547-232X","authenticated-orcid":false,"given":"Maxime","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Aouba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Avouac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cortet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Darbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"De Wazieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Dieude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Fautrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Gaxatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Eric","family":"Gottenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Granel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Greigert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Jousse-Joulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Liozon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Magnant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Mainbourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Mirault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Papo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Pu\u00e9chal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Pugnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Ramon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Roubaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Antoinette","family":"Sevestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Smets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vignal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.revmed.2024.10.011_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.revmed.2024.10.011_bib0295","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.revmed.2024.10.011_bib0300","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/acr2.11472","article-title":"Whole-country and regional incidences of giant cell arteritis in French continental and overseas territories: a 7-year nationwide database analysis","volume":"4","author":"Guittet","year":"2022","journal-title":"ACR Open Rheumatol"},{"issue":"8","key":"10.1016\/j.revmed.2024.10.011_bib0305","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.autrev.2017.05.014","article-title":"Recent advances in our understanding of giant cell arteritis pathogenesis","volume":"16","author":"Samson","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.revmed.2024.10.011_bib0310","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.1780360913","article-title":"Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis","volume":"36","author":"Roche","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"2 Suppl. 89","key":"10.1016\/j.revmed.2024.10.011_bib0315","first-page":"S103","article-title":"Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study","volume":"33","author":"Patil","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2024.10.011_bib0320","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","article-title":"The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?","volume":"55","author":"Diamantopoulos","year":"2016","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.revmed.2024.10.011_bib0335","first-page":"387","article-title":"[Diagnosis of giant cell arteritis]","volume":"73","author":"Greigert","year":"2023","journal-title":"Rev Prat"},{"key":"10.1016\/j.revmed.2024.10.011_bib0325","doi-asserted-by":"crossref","first-page":"981659","DOI":"10.3389\/fmed.2022.981659","article-title":"Evolution of ultrasound in giant cell arteritis","volume":"9","author":"Kirby","year":"2022","journal-title":"Front Med"},{"issue":"7","key":"10.1016\/j.revmed.2024.10.011_bib0330","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00259-018-4021-4","article-title":"Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy","volume":"45","author":"Nielsen","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.revmed.2024.10.011_bib0465","unstructured":"Masson E. EM-Consulte. [cit\u00e9 26 ao\u00fbt 2023]. Art\u00e9rite \u00e0 cellules g\u00e9antes (maladie de Horton)\u00a0\u2013\u00a0Pseudopolyarthrite rhizom\u00e9lique. [Disponible sur\u00a0: https:\/\/www.em-consulte.com\/article\/1248451\/arterite-a-cellules-geantes-maladie-de-horton-pseu]."},{"key":"10.1016\/j.revmed.2024.10.011_bib0340","doi-asserted-by":"crossref","first-page":"152069","DOI":"10.1016\/j.semarthrit.2022.152069","article-title":"Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica\u00a0\u2013\u00a0A systematic review and meta-analysis","volume":"56","author":"Nielsen","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.revmed.2024.10.011_bib0345","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","article-title":"Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.revmed.2024.10.011_bib0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.revmed.2024.10.011_bib0355","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/ard.2005.042770","article-title":"Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?","volume":"65","author":"Mahr","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.revmed.2024.10.011_bib0360","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/modpathol.2017.10","article-title":"Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients","volume":"30","author":"Maleszewski","year":"2017","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.revmed.2024.10.011_bib0365","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.revmed.2024.10.011_bib0370","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.revmed.2024.10.011_bib0375","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2018.07.012","article-title":"Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature","volume":"18","author":"Rinagel","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.revmed.2024.10.011_bib0380","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/rheumatology\/keaa578","article-title":"The cut-off values for the intima-media complex thickness assessed by colour Doppler sonography in seven cranial and aortic arch arteries","volume":"60","author":"Je\u0161e","year":"2021","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.revmed.2024.10.011_bib0385","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/rheumatology\/keac430","article-title":"PET\/CT of cranial arteries for a sensitive diagnosis of giant cell arteritis","volume":"62","author":"Thibault","year":"2023","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.revmed.2024.10.011_bib0390","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1007\/s00330-018-5311-8","article-title":"CT analysis of the aorta in giant-cell arteritis: a case-control study","volume":"28","author":"Berthod","year":"2018","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.revmed.2024.10.011_bib0395","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/jnnp-2014-307614","article-title":"Stroke associated with giant cell arteritis: a population-based study","volume":"86","author":"Samson","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.revmed.2024.10.011_bib0400","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/jcm11041005","article-title":"An updated review of cardiovascular events in giant cell arteritis","volume":"11","author":"de Boysson","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.revmed.2024.10.011_bib0405","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejim.2021.02.001","article-title":"Myocardial infarction during giant cell arteritis: a cohort study","volume":"89","author":"Greigert","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"10","key":"10.1016\/j.revmed.2024.10.011_bib0410","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.7326\/M23-0679","article-title":"Association between vascular 18F-fluorodeoxyglucose uptake at diagnosis and change in aortic dimensions in giant cell arteritis: a cohort study","volume":"176","author":"Moreel","year":"2023","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.revmed.2024.10.011_bib0415","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","article-title":"Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis","volume":"72","author":"Kermani","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2024.10.011_bib0420","doi-asserted-by":"crossref","first-page":"102283","DOI":"10.1016\/j.jaut.2019.05.011","article-title":"Different patterns and specific outcomes of large-vessel involvements in giant cell arteritis","volume":"103","author":"de Boysson","year":"2019","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.revmed.2024.10.011_bib0425","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3899\/jrheum.120511","article-title":"Giant cell arteritis with or without aortitis at diagnosis. A retrospective study of 22 patients with long-term follow-up","volume":"39","author":"Espitia","year":"2012","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2024.10.011_bib0430","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3899\/jrheum.181127","article-title":"Factors associated with relapse and dependence on glucocorticoids in giant cell arteritis","volume":"47","author":"Dumont","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2024.10.011_bib0435","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejim.2018.06.008","article-title":"Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: a prospective study","volume":"57","author":"Samson","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.revmed.2024.10.011_bib0440","doi-asserted-by":"crossref","first-page":"230","DOI":"10.7326\/L14-5015-2","article-title":"In response: risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis","volume":"161","author":"Tomasson","year":"2014","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.revmed.2024.10.011_bib0450","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart Br Card Soc"},{"issue":"10","key":"10.1016\/j.revmed.2024.10.011_bib0455","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.3390\/jcm11102905","article-title":"New insights into the pathogenesis of giant cell arteritis: mechanisms involved in maintaining vascular inflammation","volume":"11","author":"Greigert","year":"2022","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.revmed.2024.10.011_bib0460","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/jcm11030495","article-title":"Mimickers of large vessel giant cell arteritis","volume":"11","author":"Ramon","year":"2022","journal-title":"J Clin Med"},{"issue":"10031","key":"10.1016\/j.revmed.2024.10.011_bib0470","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","article-title":"Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Villiger","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.revmed.2024.10.011_bib0475","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.revmed.2024.10.011_bib0480","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/rheumatology\/kez091","article-title":"Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis","volume":"58","author":"Adler","year":"2019","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.revmed.2024.10.011_bib0485","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S2665-9913(21)00038-2","article-title":"Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial","volume":"3","author":"Stone","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"10.1016\/j.revmed.2024.10.011_bib0490","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3899\/jrheum.2022-1214","article-title":"Relapse risk and safety of long-term tocilizumab use among patients with giant cell arteritis: a single-enterprise cohort study","volume":"50","author":"Samec","year":"2023","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.revmed.2024.10.011_bib0495","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis","volume":"56","author":"Mahr","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.revmed.2024.10.011_bib0500","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1016\/S2665-9913(23)00101-7","article-title":"Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"5","author":"Venhoff","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"10.1016\/j.revmed.2024.10.011_bib0505","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.40044","article-title":"A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis","volume":"69","author":"Langford","year":"2017","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"6","key":"10.1016\/j.revmed.2024.10.011_bib0510","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/annrheumdis-2021-221961","article-title":"Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study","volume":"81","author":"Koster","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.revmed.2024.10.011_bib0515","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/annrheumdis-2021-221865","article-title":"Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"81","author":"Cid","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.revmed.2024.10.011_bib0520","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.semarthrit.2018.04.004","article-title":"Ustekinumab for refractory giant cell arteritis: a prospective 52-week trial","volume":"48","author":"Conway","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.revmed.2024.10.011_bib0525","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.revmed.2024.10.011_bib0530","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects","volume":"67","author":"Mart\u00ednez-Taboada","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.revmed.2024.10.011_bib0535","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/annrheumdis-2013-203586","article-title":"Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial","volume":"73","author":"Seror","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.revmed.2024.10.011_bib0540","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ando.2017.10.005","article-title":"Group 2: adrenal insufficiency: screening methods and confirmation of diagnosis","volume":"78","author":"Chanson","year":"2017","journal-title":"Ann Endocrinol"},{"issue":"12","key":"10.1016\/j.revmed.2024.10.011_bib0445","doi-asserted-by":"crossref","first-page":"e1003432","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.revmed.2024.10.011_bib0545","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.revmed.2024.10.011_bib0550","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1002\/art.22141","article-title":"Antiplatelet and anticoagulant therapy in patients with giant cell arteritis","volume":"54","author":"Lee","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.revmed.2024.10.011_bib0555","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/rheumatology\/ken480","article-title":"High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition","volume":"48","author":"Berger","year":"2009","journal-title":"Rheumatology"},{"issue":"34","key":"10.1016\/j.revmed.2024.10.011_bib0560","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.revmed.2024.10.011_bib0565","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.revmed.2024.10.011_bib0570","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jbspin.2014.10.001","article-title":"2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"81","author":"Briot","year":"2014","journal-title":"Joint Bone Spine"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324008105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324008105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T13:02:01Z","timestamp":1736427721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324008105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0248866324008105"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2024.10.011","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French protocol for the diagnosis and management of giant cell arteritis","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2024.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}